PT. PathGen Diagnostik Teknologi: Overview | LinkedIn
linkedin.com · 1,075 words · saved by 1 readers
Molecular Diagnostics for All Visit our Help Center. Go to your Settings. Learn more about Recommended Content. LinkedIn Corporation © 2024
About us PathGen Diagnostik Teknologi was established in early 2020, initiated by Susanti, with the aim of fostering a portfolio of research and training activities in collaboration with counterparts in Indonesia. The company's primary focus is on the development of low-cost and robust molecular diagnostic tools, as well as capacity building to effectively deliver these technologies. PathGen Diagnostik Teknologi is located and incubated at the Center of Innovation within the Indonesian Institute of Sciences (Lembaga Pengetahuan Indonesia/LIPI), which is a government research body in…
saved by
related reading
- Gap Mapgap-map.org
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Paradigm - Scale Agentic Researchparadigmai.com
- AI Operating System for Biopharma – Cheironcheiron.bio
- Medra – Hand over lab workmedra.ai
- Anthrogenanthrogen.com
- Evo 2: DNA Foundation Model | Arc Institutearcinstitute.org
- General Intelligence Companygeneralintelligencecompany.com
- Emergent Ventures Winnersevwinners.org
- News — Pacific 8 Venturespac8.com
- GC-Mainarep.med.harvard.edu
- the drug landscapegenome-browser-eight.vercel.app